Article Details
Retrieved on: 2021-02-26 14:26:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... an ADCC enhancer NK-cell therapy for use in combination with monoclonal antibodies or innate-cell engagers. AB-1010 is currently in a Phase I/II ...
Article found on: www.biospace.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here